| | | | | | | Sponsored | Our Novaplex™ respiratory panel assays can test for the most prevalent respiratory pathogens including bacteria and viruses, across multiple sample types. For research use only. |
|
|
|
| |
| | |
|
|
| | | | | | New UCLA-led research finds that infants born full term to mothers who were infected with COVID-19 during pregnancy had three times the risk of having respiratory distress compared with unexposed infants, even though they themselves were not infected with the virus. The risk was significantly lower ... |
|
|
|
| |
| | |
|
|
| | | | | | A 10-year follow up study of nearly 2,500 U.S. men who received prostate cancer treatment will help inform decision making in terms of treatments and side effects for a diverse population. |
|
|
|
| |
| | |
|
|
| | | | | | Cedars-Sinai Cancer investigators have used a unique precision medicine and artificial intelligence (AI) tool called the Molecular Twin Precision Oncology Platform to identify biomarkers that outperform the standard test for predicting pancreatic cancer survival. |
|
|
|
| |
| | |
|
|
| | | | Sponsored | | New vaccines and diagnostic developments have heightened the interest in RSV prevention and testing. In this webinar, pediatric, adult, and public health specialists discuss RSV epidemiology, vulnerable populations, lack of testing, multiplex diagnostics, and respiratory virus symptom overlap. |
|
|
|
| |
| | |
|
|
| | | | | | New biomarkers with improved diagnostic performance for early detection of lupus nephritis have been discovered in the University of Houston lab of Chandra Mohan. |
|
|
|
| |
| | |
|
|
| | | | Sponsored | | Tosoh G8 HbA1c analyzer can now be connected to the Sysmex XN-9000™ and XN-9100™ automated hematology systems in the U.S., Latin America and Canada. With this agreement, Tosoh Bioscience aims to expand its HbA1c offering to the high-volume testing market and further automate hemoglobin A1c testing. |
|
|
|
| |
| | |
|
|
| | | | | | Researchers from the Johns Hopkins Bloomberg School of Public Health have developed a single “universal risk prediction model” for cardiovascular disease that, in initial tests, works well for patients who already have cardiovascular disease as well as patients who do not but who may be at risk for ... |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
